Bongiorno Maria Rita, Doukaki Spyridoula, Aricò Mario
Department of Dermatology, University of Palermo, Sicily, Palermo, Italy.
J Med Case Rep. 2010 Jan 25;4:22. doi: 10.1186/1752-1947-4-22.
Neurofibromatosis type 1 is an autosomal dominant disorder that occurs across all ethnic groups and affects approximately one in 4000 individuals. One of the most noticeable characteristics of the disease is the development of neurofibromas.
A total of 258 patients (131 women, 127 men) with neurofibromatosis type 1 were evaluated between 1994 and 2004 in our hospital's dermatology department. Nine patients (3.45%, 95% confidence limits 1.22 to 5.68) had neurofibromas of the breast. One of these nine patients presented with an extensive congenital plexiform neurofibroma in the outer quadrants of her right breast, extending to the nipple-areolar complex. Meanwhile, three patients had more than one neurofibroma on the nipple-areolar complexes. Three patients had a family history of neurofibroma. Over the years 1994 to 2004, the cutaneous lesions were not associated with any malignancies. Presenting symptoms were related to conditions such as increasing size of the mass, and associated loss of function and pain.
This study suggests that the changes are limited to particular subgroups. That neurofibromatosis is more prevalent in women (7 women and 2 men) suggests that being female could be a susceptibility factor for the development of neurofibromas of the nipple-areolar complexes. There are few reports in the literature describing breast carcinomas in association with von Recklinghausen disease. It has been speculated that the presence of multiple neurofibromas of the breast may obscure a breast mass at palpation, leading to a delay in clinical detection. We suggest that patients with neurofibromas of the breast have more rigorous clinical and mammographic screening of the breast during adulthood to determine the presence or absence of malignancies. The finding that both the neurofibromatosis type 1 gene and a breast cancer predisposition gene are located in close proximity on chromosome 17q makes the association of these two conditions intriguing.
1型神经纤维瘤病是一种常染色体显性疾病,在所有种族中均有发生,发病率约为4000分之一。该疾病最显著的特征之一是神经纤维瘤的形成。
1994年至2004年期间,我院皮肤科对总共258例1型神经纤维瘤病患者(131名女性,127名男性)进行了评估。9例患者(3.45%,95%置信区间为1.22至5.68)患有乳腺神经纤维瘤。这9例患者中的1例右侧乳房外象限有广泛的先天性丛状神经纤维瘤,延伸至乳头乳晕复合体。同时,3例患者的乳头乳晕复合体上有不止一个神经纤维瘤。3例患者有神经纤维瘤家族史。在1994年至2004年期间,皮肤病变未与任何恶性肿瘤相关。出现的症状与肿块大小增加、功能丧失和疼痛等情况有关。
本研究表明,这些变化仅限于特定亚组。神经纤维瘤病在女性中更为普遍(7名女性和2名男性),这表明女性可能是乳头乳晕复合体神经纤维瘤形成的易感因素。文献中很少有关于与冯·雷克林豪森病相关的乳腺癌的报道。据推测,乳房多发性神经纤维瘤的存在可能会在触诊时掩盖乳房肿块,导致临床检测延迟。我们建议,患有乳腺神经纤维瘤的患者在成年期对乳房进行更严格的临床和乳房X线筛查,以确定是否存在恶性肿瘤。1型神经纤维瘤病基因和乳腺癌易感基因都位于17号染色体q臂上的相近位置,这一发现使得这两种疾病的关联颇具吸引力。